Kinase Inhibitors Market

Table of Contents

1 Executive Summary    
     
2 Preface    
 2.1 Abstract   
 2.2 Stake Holders   
 2.3 Research Scope   
 2.4 Research Methodology   
  2.4.1 Data Mining  
  2.4.2 Data Analysis  
  2.4.3 Data Validation  
  2.4.4 Research Approach  
 2.5 Research Sources   
  2.5.1 Primary Research Sources  
  2.5.2 Secondary Research Sources  
  2.5.3 Assumptions  
     
3 Market Trend Analysis    
 3.1 Introduction   
 3.2 Drivers   
 3.3 Restraints   
 3.4 Opportunities   
 3.5 Threats   
 3.6 Application Analysis   
 3.7 End User Analysis   
 3.8 Emerging Markets   
 3.9 Impact of Covid-19   
     
4 Porters Five Force Analysis    
 4.1 Bargaining power of suppliers   
 4.2 Bargaining power of buyers   
 4.3 Threat of substitutes   
 4.4 Threat of new entrants   
 4.5 Competitive rivalry   
     
5 Global Kinase Inhibitors Market, By Type    
 5.1 Introduction   
 5.2 Receptor Tyrosine Kinase Inhibitors   
  5.2.1 Platelet-derived Growth Factor Receptors (PDGFR)   
  5.2.2 Vascular Endothelial Growth Factor Receptor (VEGFR)  
  5.2.3 Anaplastic lymphoma kinase (ALK)  
  5.2.4 Human Epidermal Growth Factor Receptor 2 (HER2)  
  5.2.5 Estimated Glomerular Filtration Rate (EGFR)  
 5.3 Non-receptor Tyrosine Kinase Inhibitors   
  5.3.1 Mesenchymal Epithelial Transition Growth Factor (c-MET)  
  5.3.2 Spleen Tyrosine Kinase (SYK) Inhibitors  
  5.3.3 Bruton’s Tyrosine Kinase (BTK) Inhibitors  
  5.3.4 BCR-ABL  
  5.3.5 Janus Kinase (JAK) Inhibitor  
 5.4 Angiogenesis Inhibitors   
 5.5 Protein Kinase C Inhibitors   
 5.6 RHO Kinase Inhibitors   
 5.7 Multikinase inhibitors   
 5.8 Serine/Threonine Kinase Inhibitors   
 5.9 Tyrosin kinase inhibitors (TKI)   
 5.10 Threonine kinase inhibitor   
 5.11 mTOR Kinase Inhibitors   
 5.12 BRAF Inhibitors   
 5.13 Cyclin Dependant Kinase Inhibitor   
 5.14 Aurora Kinase Inhibitors   
 5.15 MAP/MEK Kinase Inhibitors   
 5.16 Humanized Monoclonal Antibody   
 5.17 Chimeric Monoclonal Antibody   
 5.18 JNK Inhibitors   
 5.19 PI3K Inhibitors   
 5.20 Other Types   
  5.20.1 Monoclonal  Antibody Kinase Inhibitor  
     
6 Global Kinase Inhibitors Market, By Distribution Channel    
 6.1 Introduction   
 6.2 Independent Pharmacies   
 6.3 Hospital Pharmacies   
 6.4 Online Pharmacies   
     
7 Global Kinase Inhibitors Market, By Application    
 7.1 Introduction   
 7.2 Inflammatory Diseases   
 7.3 Oncology   
  7.3.1 Lung Cancer  
  7.3.2 Renal Cell Cancer  
  7.3.3 Breast Cancer  
     
8 Global Kinase Inhibitors Market, By End User    
 8.1 Introduction    
 8.2 Scientific Research Labs   
 8.3 Hospitals   
 8.4 Academic Institutes   
 8.5 Healthcare Facilities   
 8.6 Pharmaceutical Companies   
 8.7 Private and Government Research Institutes   
     
9 Global Kinase Inhibitors Market, By Geography     
 9.1 Introduction   
 9.2 North America   
  9.2.1 US  
  9.2.2 Canada  
  9.2.3 Mexico  
 9.3 Europe   
  9.3.1 Germany  
  9.3.2 UK  
  9.3.3 Italy  
  9.3.4 France  
  9.3.5 Spain  
  9.3.6 Rest of Europe  
 9.4 Asia Pacific   
  9.4.1 Japan  
  9.4.2 China  
  9.4.3 India  
  9.4.4 Australia  
  9.4.5 New Zealand  
  9.4.6 South Korea  
  9.4.7 Rest of Asia Pacific  
 9.5 South America   
  9.5.1 Argentina  
  9.5.2 Brazil  
  9.5.3 Chile  
  9.5.4 Rest of South America  
 9.6 Middle East & Africa   
  9.6.1 Saudi Arabia  
  9.6.2 UAE  
  9.6.3 Qatar  
  9.6.4 South Africa  
  9.6.5 Rest of Middle East & Africa  
     
10 Key Developments    
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures   
 10.2 Acquisitions & Mergers   
 10.3 New Product Launch   
 10.4 Expansions   
 10.5 Other Key Strategies   
     
11 Company Profiling    
 11.1 Меrсk Ѕеrоnо Ѕа   
 11.2 Nоvаrtіѕ Іntеrnаtіоnаl Аg   
 11.3 Incyte Corporation   
 11.4 Glaxo SmithKline    
 11.5 Суtrх Соrроrаtіоn   
 11.6 Оѕі Рhаrmасеutісаlѕ Llс   
 11.7 AstraZeneca, Eisai Co., Ltd.   
 11.8 Bristol-Myers Squibb   
 11.9 Bayer AG   
 11.10 Pfizer Inc.   
 11.11 Takeda Pharmaceutical Company Limited   
 11.12 Boehringer Ingelheim GmbH   
 11.13 Eisai Co., Ltd.   
 11.14 Johnson & Johnson   
 11.15 Еtоn Віоѕсіеnсе Іnс.   
 11.16 F. Hoffmann-La Roche Ltd  

List of Tables     
1 Global Kinase Inhibitors Market Outlook, By Region (2018-2027) ($MN)    
2 Global Kinase Inhibitors Market Outlook, By Type (2018-2027) ($MN)    
3 Global Kinase Inhibitors Market Outlook, By Receptor Tyrosine Kinase Inhibitors (2018-2027) ($MN)    
4 Global Kinase Inhibitors Market Outlook, By Platelet-derived Growth Factor Receptors (PDGFR) (2018-2027) ($MN)    
5 Global Kinase Inhibitors Market Outlook, By Vascular Endothelial Growth Factor Receptor (VEGFR) (2018-2027) ($MN)    
6 Global Kinase Inhibitors Market Outlook, By Anaplastic lymphoma kinase (ALK) (2018-2027) ($MN)    
7 Global Kinase Inhibitors Market Outlook, By Human Epidermal Growth Factor Receptor 2 (HER2) (2018-2027) ($MN)    
8 Global Kinase Inhibitors Market Outlook, By Estimated Glomerular Filtration Rate (EGFR) (2018-2027) ($MN)    
9 Global Kinase Inhibitors Market Outlook, By Non-receptor Tyrosine Kinase Inhibitors (2018-2027) ($MN)    
10 Global Kinase Inhibitors Market Outlook, By Mesenchymal Epithelial Transition Growth Factor (c-MET) (2018-2027) ($MN)    
11 Global Kinase Inhibitors Market Outlook, By Spleen Tyrosine Kinase (SYK) Inhibitors (2018-2027) ($MN)    
12 Global Kinase Inhibitors Market Outlook, By Bruton’s Tyrosine Kinase (BTK) Inhibitors (2018-2027) ($MN)    
13 Global Kinase Inhibitors Market Outlook, By BCR-ABL (2018-2027) ($MN)    
14 Global Kinase Inhibitors Market Outlook, By Janus Kinase (JAK) Inhibitor (2018-2027) ($MN)    
15 Global Kinase Inhibitors Market Outlook, By Angiogenesis Inhibitors (2018-2027) ($MN)    
16 Global Kinase Inhibitors Market Outlook, By Protein Kinase C Inhibitors (2018-2027) ($MN)    
17 Global Kinase Inhibitors Market Outlook, By RHO Kinase Inhibitors (2018-2027) ($MN)    
18 Global Kinase Inhibitors Market Outlook, By Multikinase inhibitors (2018-2027) ($MN)    
19 Global Kinase Inhibitors Market Outlook, By Serine/Threonine Kinase Inhibitors (2018-2027) ($MN)    
20 Global Kinase Inhibitors Market Outlook, By Tyrosin kinase inhibitors (TKI) (2018-2027) ($MN)    
21 Global Kinase Inhibitors Market Outlook, By Threonine kinase inhibitor (2018-2027) ($MN)    
22 Global Kinase Inhibitors Market Outlook, By mTOR Kinase Inhibitors (2018-2027) ($MN)    
23 Global Kinase Inhibitors Market Outlook, By BRAF Inhibitors (2018-2027) ($MN)    
24 Global Kinase Inhibitors Market Outlook, By Cyclin Dependant Kinase Inhibitor (2018-2027) ($MN)    
25 Global Kinase Inhibitors Market Outlook, By Aurora Kinase Inhibitors (2018-2027) ($MN)    
26 Global Kinase Inhibitors Market Outlook, By MAP/MEK Kinase Inhibitors (2018-2027) ($MN)    
27 Global Kinase Inhibitors Market Outlook, By Humanized Monoclonal Antibody (2018-2027) ($MN)    
28 Global Kinase Inhibitors Market Outlook, By Chimeric Monoclonal Antibody (2018-2027) ($MN)    
29 Global Kinase Inhibitors Market Outlook, By JNK Inhibitors (2018-2027) ($MN)    
30 Global Kinase Inhibitors Market Outlook, By PI3K Inhibitors (2018-2027) ($MN)    
31 Global Kinase Inhibitors Market Outlook, By Other Types (2018-2027) ($MN)    
32 Global Kinase Inhibitors Market Outlook, By Monoclonal  Antibody Kinase Inhibitor (2018-2027) ($MN)    
33 Global Kinase Inhibitors Market Outlook, By Distribution Channel (2018-2027) ($MN)    
34 Global Kinase Inhibitors Market Outlook, By Independent Pharmacies (2018-2027) ($MN)    
35 Global Kinase Inhibitors Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)    
36 Global Kinase Inhibitors Market Outlook, By Online Pharmacies (2018-2027) ($MN)    
37 Global Kinase Inhibitors Market Outlook, By Application (2018-2027) ($MN)    
38 Global Kinase Inhibitors Market Outlook, By Inflammatory Diseases (2018-2027) ($MN)    
39 Global Kinase Inhibitors Market Outlook, By Oncology (2018-2027) ($MN)    
40 Global Kinase Inhibitors Market Outlook, By Lung Cancer (2018-2027) ($MN)    
41 Global Kinase Inhibitors Market Outlook, By Renal Cell Cancer (2018-2027) ($MN)    
42 Global Kinase Inhibitors Market Outlook, By Breast Cancer (2018-2027) ($MN)    
43 Global Kinase Inhibitors Market Outlook, By End User (2018-2027) ($MN)    
44 Global Kinase Inhibitors Market Outlook, By Scientific Research Labs (2018-2027) ($MN)    
45 Global Kinase Inhibitors Market Outlook, By Hospitals (2018-2027) ($MN)    
46 Global Kinase Inhibitors Market Outlook, By Academic Institutes (2018-2027) ($MN)    
47 Global Kinase Inhibitors Market Outlook, By Healthcare Facilities (2018-2027) ($MN)    
48 Global Kinase Inhibitors Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)    
49 Global Kinase Inhibitors Market Outlook, By Private and Government Research Institutes (2018-2027) ($MN)    
     
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.     

List of Figures

RESEARCH METHODOLOGY

We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

• Product Lifecycle Analysis
• Competitor analysis
• Risk analysis
• Porters Analysis
• PESTEL Analysis
• SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.

Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

• Leading Companies
• Suppliers & Distributors
• Manufacturers
• Consumers
• Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.

For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.